Resources/
Phil Blog
Phil Blog
Drug Channels: Harnessing the Power of Comprehensive Data to Drive GTN
Growing market access barriers are compelling retail and specialty-lite pharmaceutical manufacturers to seek new approaches to optimize revenue and enhance patient access. Traditional data sources and siloed solutions are no longer sufficient to address the challenges of formulary exclusions and rising patient out-of-pocket costs. Success in today's market requires comprehensive visibility across the patient journey to drive meaningful improvements in gross-to-net (GTN) performance.
Meet Bob Schumaker, Vice President of Operations at PHIL
As VP of Operations at PHIL, Bob Schumaker champions a collaborative approach that brings together healthcare stakeholders to improve patient care. Drawing from his extensive background, Bob has spent the last five years building and scaling PHIL's partnership operations with a laser focus on improving patients' lives. Can you tell us a little bit about what your role as VP of Operations entails
How Can Pharma Manufacturers Improve Patient Engagement in 2025?
Patient engagement is a critical factor for brand success. Not only does patient engagement benefit patients by addressing unmet needs more effectively, but it has also proven to be a powerful driver of financial value. A groundbreaking study revealed that an investment of $100,000 in patient engagement could increase net present value and expected net present value by more than 500-fold the investment – the equivalent of accelerating a pre-phase 2 product launch by 2.5 years
8 Patient Access Trends Pharma Leaders Should Consider in 2025
With a new year brings new brand goals. Retail and specialty-lite brand teams continue to face an evolving patient access landscape that's significantly impacting their commercialization strategies. From the expansion of direct-to-consumer (DTC) models to the growing importance of real-world evidence, these emerging trends are reshaping how patients interact with healthcare systems and access prescribed therapies
Meet Maria Klagos, VP People Operations at PHIL
In our latest employee spotlight, we sit down with Maria Klagos, our new Head of People, who brings a wealth of experience in scaling HR functions at high-growth startups. We explore her unique background, her vision for PHIL’s culture, and the personal experiences that have shaped her professional journey. Please tell us a little bit about yourself and your new role at PHIL I joined PHIL as the VP of People Operations this past May
Ready to learn more?
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.
